Litcius/Paper detail

The Pan-Immune-Inflammation Value in Patients with Metastatic Melanoma Receiving First-Line Therapy

Giovanni Fucà, Teresa Beninato, Marta Bini, Laura Mazzeo, Lorenza Di Guardo, Carolina Cimminiello, Giovanni Randon, Giulia Apollonio, Ilaria Bisogno, Marta Del Vecchio, C Lauria Pantano, Massimo Di Nicola, Filippo de Braud, Michele Del Vecchio

2021Targeted Oncology61 citationsDOI

Topics & Concepts

MedicineInternal medicineHazard ratioImmunotherapyGastroenterologyOncologyConfidence intervalMelanomaNeutrophil to lymphocyte ratioOdds ratioTargeted therapyResponse Evaluation Criteria in Solid TumorsCancerLymphocyteProgressive diseaseDiseaseCancer researchCancer Immunotherapy and BiomarkersInflammatory Biomarkers in Disease PrognosisCutaneous Melanoma Detection and Management
The Pan-Immune-Inflammation Value in Patients with Metastatic Melanoma Receiving First-Line Therapy | Litcius